IMUX · Immunic Inc. Common Stock
View on chartInsiders & Stakes
| Muehler Andreas Chief Medical Officer | ▲ Buy | Open Market | 297,986 Shares held | 5/12/2022 | View profile |
| Rudick Richard Alan Director | ▲ Buy | Open Market | 230,375 Shares held | 6/3/2025 | View profile |
| Neermann Joerg Director | ▲ Buy | Open Market | 200,000 Shares held | 6/5/2025 | View profile |
| Whaley Glenn Chief Financial Officer | ▲ Buy | Open Market | 95,510 Shares held | 6/3/2025 | View profile |
| Duane Nash Executive Chairman | ▲ Buy | Open Market | 36,032 Shares held | 6/13/2025 | View profile |
| Vitt Daniel President and CEO | ▲ Buy | Open Market | 29,000 Shares held | 6/4/2025 | View profile |
| Jason Tardio Chief Operating Officer | ▲ Buy | Open Market | 12,512 Shares held | 6/5/2025 | View profile |
Transaction History
| Duane Nash | ▲ Buy | Open Market | 20,000 | $17K | 6/13/2025 |
| Jason Tardio | ▲ Buy | Open Market | 12,512 | $10K | 6/5/2025 |
| Neermann Joerg | ▲ Buy | Open Market | 30,000 | $23K | 6/5/2025 |
| Vitt Daniel | ▲ Buy | Open Market | 15,000 | $12K | 6/4/2025 |
| Neermann Joerg | ▲ Buy | Open Market | 70,000 | $54K | 6/4/2025 |
| Whaley Glenn | ▲ Buy | Open Market | 45,000 | $32K | 6/3/2025 |
| Rudick Richard Alan | ▲ Buy | Open Market | 143,075 | $100K | 6/3/2025 |
| Whaley Glenn | ▲ Buy | Grant | 25,000 | $14K | 5/30/2025 |
| Rudick Richard Alan | ▲ Buy | Open Market | 87,300 | $100K | 11/12/2024 |
| Vitt Daniel | ▲ Buy | Open Market | 14,000 | $18K | 2/26/2024 |
| Whaley Glenn | ▲ Buy | Open Market | 5,000 | $9K | 5/15/2023 |
| Neermann Joerg | ▲ Buy | Open Market | 47,000 | $59K | 12/14/2022 |
| Neermann Joerg | ▲ Buy | Open Market | 35,000 | $44K | 12/13/2022 |
| Neermann Joerg | ▲ Buy | Open Market | 18,000 | $25K | 11/23/2022 |
| Vitt Daniel | ▲ Buy | Open Market | 8,000 | $11K | 11/22/2022 |
| Whaley Glenn | ▲ Buy | Open Market | 5,000 | $7K | 11/7/2022 |
| Vitt Daniel | ▲ Buy | Open Market | 5,000 | $15K | 6/3/2022 |
| Whaley Glenn | ▲ Buy | Open Market | 3,500 | $11K | 6/3/2022 |
| Muehler Andreas | ▲ Buy | Open Market | 3,500 | $18K | 5/12/2022 |
| Whaley Glenn | ▲ Buy | Open Market | 3,000 | $15K | 5/12/2022 |
| Duane Nash | ▲ Buy | Open Market | 10,000 | $50K | 5/12/2022 |
| Duane Nash | ▼ Sell | Gift | 6,000 | $0 | 5/12/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Immunic Presents Four Abstracts at MSToronto2026
Immunic announced that four of its research abstracts were accepted for presentation at the 10th Joint ACTRIMS-ECTRIMS Meeting, known as MSToronto2026. This event highlights the company's ongoing scientific activity in its field. The stock is currently trading near its 52-week low, with an RSI of 22.5 indicating oversold conditions.
Immunic Presents Four Abstracts at MSToronto2026. Immunic announced that four of its research abstracts were accepted for presentation at the 10th Joint ACTRIMS-ECTRIMS Meeting, known as MSToronto2026. This event highlights the company's ongoing scientific activity in its field. The stock is currently trading near its 52-week low, with an RSI of 22.5 indicating oversold conditions.